H.R. 5568
Referred to CommitteeNational Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2018
Latest Action
Referred to the House Committee on Energy and Commerce.
4/18/2018 • House
Summary
National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2018
This bill authorizes the Food and Drug Administration to partner with institutions of higher education to designate them as National Centers of Excellence in Continuous Pharmaceutical Manufacturing for the purpose of studying and recommending improvements to the process of continuous manufacturing of medications. (Currently, most medications are manufactured in batches.)
Introduced in House • 4/18/2018
Topics & Subjects
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (2)
Party Breakdown
Sponsor
Cosponsors (1)
Bill Journey
Originated in the House
Introduced
April 18, 2018
Referred to the House Committee on Energy and Commerce.
Committee Review
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law